Clinical Trial Update: Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19 [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial on safety and efficacy of hyperbaric oxygen for ARDS in COVID-19 patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome
• Respiratory Failure
• Sars

Snippet

Sponsor: Karolinska Institutet | Conditions: SARS (Severe Acute Respiratory Syndrome), Cytokine Storm | Phase 2, Phase 3 | Status: TERMINATED